Capital Analysts, LLC Pfizer Inc Transaction History

Capital Analysts, LLC

$2.45 Billion
Q3 2024

A detailed history of Capital Analysts, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Analysts, LLC holds 21,232 shares of PFE stock, worth $549,696. This represents 0.03% of its overall portfolio holdings.

Number of Shares

21,232

Previous 21,961 3.32%

Holding current value

$549,696

Previous $615,000 0.16%

% of portfolio

0.03%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $20,193 - $22,883	-729 Reduced 3.32%	21,232 $614,000
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $44,659 - $52,332	1,768 Added 8.76%	21,961 $615,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $33,760 - $38,767	-1,304 Reduced 6.07%	20,193 $560,000
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $1.17 Million - $1.52 Million	-44,884 Reduced 67.62%	21,497 $619,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $24,998 - $29,220	-779 Reduced 1.16%	66,381 $2.2 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $101,461 - $117,388	2,809 Added 4.37%	67,160 $2.46 Million
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $152,084 - $197,992	3,861 Added 6.38%	64,351 $2.63 Million
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $58,784 - $76,736	1,408 Added 2.38%	60,490 $3.1 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $46,516 - $56,785	1,063 Added 1.83%	59,082 $2.59 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $53,649 - $63,611	1,153 Added 2.03%	58,019 $3.04 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $455,715 - $564,689	-9,961 Reduced 14.91%	56,866 $2.94 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $35,328 - $52,368	-855 Reduced 1.26%	66,827 $3.95 Million
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $82,739 - $106,285	2,108 Added 3.21%	67,682 $2.91 Million
Q2 2021 Nov 15, 2021	SELL	$35.91 - $40.68 $286,777 - $324,870	-7,986 Reduced 10.86%	65,574 $2.57 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $243,541 - $275,891	6,782 Added 10.16%	73,560 $2.88 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $672,412 - $758,346	20,078 Added 42.99%	66,778 $2.42 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $104,560 - $132,957	-3,124 Reduced 6.27%	46,700 $1.72 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $17,303 - $20,301	-545 Reduced 1.08%	49,824 $1.83 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $31,595 - $38,330	-1,049 Reduced 2.04%	50,369 $1.65 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $145,989 - $208,586	5,401 Added 11.74%	51,418 $1.68 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $74,333 - $84,358	2,258 Added 5.16%	46,017 $1.8 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $39,962 - $51,819	1,230 Added 2.89%	43,759 $1.57 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $17,084 - $19,182	-462 Reduced 1.07%	42,529 $1.84 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $174,600 - $191,827	4,656 Added 12.15%	42,991 $1.83 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $28,236 - $32,193	734 Added 1.95%	38,335 $1.67 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $14,925 - $18,103	433 Added 1.16%	37,601 $0
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $71,830 - $76,578	2,178 Added 6.22%	37,168 $0
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $15,252 - $17,695	478 Added 1.39%	34,990 $1.24 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $1.15 Million - $1.22 Million	34,507 Added 690140.0%	34,512 $1.25 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $1.2 Million - $1.27 Million	-36,079 Reduced 99.99%	5 $1,000
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $1.12 Million - $1.23 Million	36,084	36,084 $1.29 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Pfizer Inc Transaction History